First Philly Risperdal Mass Tort Case Heads To Jury
A Philadelphia jury began deliberations Friday after being urged to find that a Johnson & Johnson unit concealed crucial data linking antipsychotic drug Risperdal to the medical condition gynecomastia, leading an...To view the full article, register now.
Already a subscriber? Click here to view full article